Alnylam Pharmaceuticals
ALNY
#1109
Rank
โ‚ฌ19.28 B
Marketcap
143,99ย โ‚ฌ
Share price
5.41%
Change (1 day)
-63.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company